This announcement is a separate document:
共同药业：监事会关于公司2023年限制性股票激励计划预留授予激励对象名单的核查意见及公示情况说明
Kyodo Pharmaceutical: Explanation of the supervisory board's inspection opinions and disclosure on the list of incentive recipients reserved for the company's 2023 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated